Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.

Oncology Reports
Rokas RačkauskasPeter Schemmer

Abstract

Cholangiocarcinoma (CCC) is an aggressive malignancy with poor therapeutic options and pronounced chemotherapy resistance. The bioactive broccoli substance, sulforaphane (SFN), is a promising new therapeutic option since it has been found to induce therapeutic effects in both experimental and epidemiological studies in various tumor entities. Thus, the present study was designed to assess the effect of SFN on cisplatin sensitivity in CCC. Human HuCCT-1 and TFK-1 cells, representing intrahepatic and extrahepatic CCC, respectively, were treated with cisplatin and SFN. Viability, the platinated DNA content, and apoptosis were assessed using both MTT assay and flow cytometry, while western blotting was used to analyze the expression of proteins involved in apoptosis and DNA damage. Whereas cisplatin was largely ineffective, SFN only therapy significantly decreased the viability of both CCC cell lines. The combination of SFN with cisplatin increased cisplatin cytotoxicity, which was particularly pronounced relatively early at 36 h after treatment. Apoptosis, which was reflected by the cleavage of caspase-3 and PARP, was significantly enhanced. Notably, only cisplatin was found to induce the expression of proteins involved in the DNA...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangG H Posner
Jun 1, 1989·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·M MiyagiwaH Sasaki
Sep 1, 1995·The Tohoku Journal of Experimental Medicine·S SaijyoS Matsuno
Oct 1, 1996·Annals of Surgery·A NakeebJ L Cameron
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Feb 28, 2007·British Journal of Cancer·F Eckel, R M Schmid
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
Mar 31, 2007·Cellular and Molecular Life Sciences : CMLS·N JugeM Traka
Apr 26, 2007·Annals of Surgery·Michelle L DeOliveiraRichard D Schulick
Feb 5, 2010·Leukemia·L-J MahT C Karagiannis
Sep 3, 2010·Journal of Nucleic Acids·Monika PodhoreckaPrzemyslaw Bozko
Oct 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Georgios KallifatidisIngrid Herr
Nov 22, 2014·Deutsches Ärzteblatt International·Arndt VogelUlf Neumann
Apr 14, 2015·Molecular Cell·Xinjian LiuChuan-Yuan Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.